About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD41.00
- USD41.00
- USD38.30
- USD52.26
- 23.90%
- 19M
- 16.55k
- 18.79k
- 118M
- 4.02
- 694.10%
Stock News
2 hours ago
4 'good enough' financial moves to reach your goals with 'less time and hassle,' from a money expert
CNBC
2 hours ago
The Fed’s biggest decision this week could have nothing to do with interest rates
MarketWatch
6 hours ago
Investors Keep Eye On Fed Decision While Adobe, Broadcom Set To Report Earnings
SeekingAlpha
6 hours ago
12 Years With Zero Gains: Can Your Retirement Plan Survive A 'Lost Decade?'
SeekingAlpha